57.62

0.37% 0.21

After Hours: 57.17 -0.45 -0.78%

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $57.62, with a volume of 1.16M. It is up +0.37% in the last 24 hours and up +33.13% over the past month. Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Previous Close:

$57.41

Open:

$57.41

24h Volume:

1.16M

Relative Volume:

0.90

Market Cap:

$3.53B

Revenue:

$391.56M

Net Income/Loss:

$-76.58M

P/E Ratio:

-45.21

EPS:

-1.2745

Net Cash Flow:

$-86.72M

1W Performance:

+12.61%

1M Performance:

+33.13%

6M Performance:

+79.84%

1Y Performance:

+45.87%

1-Day Range:

$56.05

$59.90

1-Week Range:

$47.11

$59.90

52-Week Range:

$23.30

$59.90

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1112)

Industry

Diagnostics & Research (52)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

979

Twitter

@TwistBioscience

Next Earnings Date

2026-02-02

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	57.62	3.52B	391.56M	-76.58M	-86.72M	-1.2745
TMO Thermo Fisher Scientific Inc	531.67	195.93B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	198.14	140.56B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	580.76	46.39B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	119.77	34.02B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	326.20	32.49B	3.17B	642.63M	516.49M	10.77

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-25	Initiated	Stephens	Overweight
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

07:45 AM

Guggenheim reiterates Twist Bioscience stock rating on Amazon tie-up - Investing.com

07:45 AM

Apr 14, 2026

Insider share sales disclosed — Company (NASDAQ: TWST) lists recent dispositions - Stock Titan

Apr 14, 2026

Twist Bioscience stock hits 52-week high at $57.90 By Investing.com - Investing.com Australia

Apr 14, 2026

Apr 13, 2026

TWST (NASDAQ: TWST) Form 144: 2,597 vested shares proposed for sale - Stock Titan

Apr 09, 2026

Apr 08, 2026

Published on: 2026-04-09 01:15:19 - baoquankhu1.vn

Apr 08, 2026

TWST Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 08, 2026

Apr 07, 2026